Verbatim response from Claude
This is a fast-moving area, so here's an honest breakdown:
Current Situation (as of early 2025)
The FDA declared the semaglutide shortage over, which restricted most compounding of GLP-1s like semaglutide (Ozempic/Wegovy).
Services Still Operating (with caveats)
Hims & Hers - Pivoted to personalized/combination compounds, though facing ongoing legal/regulatory pressure
Empower Pharmacy & similar 503B compounders - Some still supply through providers for "clinical need" cases
Sublocade/specialty clinics - Some independent telehealth providers still work with 503A compounding pharmacies for documented individual cases
Important Honest Notes
- The landscape changes weekly - what's available today may not be tomorrow
- Many services claiming to offer compounded semaglutide may be operating in a gray area
- Tirzepatide (Mounjaro/Zepbound) shortage status has been separate - check FDA's current shortage list
- Some providers are shifting to oral semaglutide or branded alternatives
My Recommendation
Check r/Semaglutide or r/Ozempic communities for real-time user experiences, and verify any provider's pharmacy is an FDA-registered 503B facility.
Want info on alternatives like branded medication access programs?